Original Query: ALL
Previous Study | Return to List | Next Study

"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00840333
Recruitment Status : Completed
First Posted : February 10, 2009
Last Update Posted : January 19, 2018
Information provided by (Responsible Party):
Horizon Pharma USA, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2009
  Study Completion Date : December 2009